MedTrace Logo

Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain

NCT04166045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-07-26

No results posted yet for this study

Summary

Clinical study to determine the responder rate of the TheraNova Migraine Treatment System to that of a sham control treatment.

Conditions

  • Episodic Migraine

Interventions

DEVICE

Sham Treatment Location

The device applies transcutaneous electrical nerve stimulation to the bicep

DEVICE

Verum Treatment Location

The device applies transcutaneous electrical nerve stimulation to the hand

Sponsors & Collaborators

  • Theranova, L.L.C.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-12
Primary Completion
2021-04-29
Completion
2021-04-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04166045 on ClinicalTrials.gov